The Management of Neuroendocrine Tumours: A Nutritional Viewpoint.
NetNutr
Association Between Mediterranean Diet and Neuroendocrine Tumours.
1 other identifier
observational
100
1 country
1
Brief Summary
Nutritional status in patients with neuroendocrine tumours (NETs), especially of gastroenteropancreatic origin, can be deeply affected by excessive production of gastrointestinal hormones, peptides, and amines, which can lead to malabsorption, diarrhoea, steatorrhea, and altered gastrointestinal motility. Besides, the surgical and/or medical management of NETs can lead to alteration of gastrointestinal secretory, motor, and absorptive functions, with both dietary and nutritional consequences. Indeed, disease-related malnutrition is a frequently encountered yet both underrecognized and understudied clinical phenomenon in patients with NETs, with substantial prognostic and socioeconomic consequences. Most of these conditions can be alleviated by a tailored nutritional approach, also with the aim of improving the efficacy of cancer treatments. In this setting, skilled nutritionists can play a fundamental role in the multidisciplinary health care team in NETs management and their presence should be recommended.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedFirst Submitted
Initial submission to the registry
July 10, 2018
CompletedFirst Posted
Study publicly available on registry
July 19, 2018
CompletedJuly 19, 2018
July 1, 2018
1 month
July 10, 2018
July 10, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Adherence to Mediterranean Diet by Predimed Questionnaire
Validated 14-item tool of adherence to the Mediterranean diet, with three categories of adherence (≤5, low adherence, 6-9, average adherence and ≥10 points, high adherence)
December 2017 to June 2018
Secondary Outcomes (1)
Body composition
December 2017 to June 2018
Interventions
We aim to determine the effects of the traditional Mediterranean Diet on neuroendocrine tumours
Eligibility Criteria
One hundred patients with neuroendocrine tumours (NETs) were consecutively enrolled (aged 18-60 years) in this cross-sectional observational study. Anthropometric measures were evaluated. A validated 14-item questionnaire PREDIMED (PREvención con DIeta MEDiterránea) was used for the assessment of adherence to the MD. Dietary data were collected by a 7-day food records.
You may qualify if:
- patients with neuroendocrine tumours (NETs)
You may not qualify if:
- age\>65 years
- \< BMI 19 kg/m2
- vegetarians
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Silvia Savastano
Naples, 80131, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 10, 2018
First Posted
July 19, 2018
Study Start
November 1, 2017
Primary Completion
December 1, 2017
Study Completion
June 30, 2018
Last Updated
July 19, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share